North America Immunoassay market demand analysis defines that the largest market share of 35% in 2022 and is forecasted to hold the same position during the forecast period. The rising demand is attributed to increase in the incidence of cancer and the easy availability of technologically advanced diagnostic techniques
NEWARK, Del, Aug. 11, 2022 (GLOBE NEWSWIRE) -- The immunoassay market is expected to observe growth at a CAGR of 5% and is anticipated to touch a valuation of USD 45.78 bn by 2032, while it holds a revenue of USD 29.51 Bn in 2022
The dynamic shift from the last forecast period (2017-2021) to the current forecast period (2022-2032) is significant. The major factors that have shaped the growth dynamics are the advent of covid-19, the geriatric population, and rising awareness around health
With the environment changing and climate change-based diseases and viruses growing in the urban and rural areas, the demand for vaccines is on a rise. The immunoassay market survey explains that the tests of the effectiveness of these vaccines are conducted through immunoassays tests that include the strength of antibodies in the immune system, fueling the sales of immunoassay testing kits.
Get a Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15437
Rising awareness, government research and development programs, and covid-19's spread has collectively flourished the demand for the antibodies testing systems. Hence, it has expanded the immunoassay market share in the global market
This fueled the market’s growth prospects and brought opportunities for the new medical and healthcare market players to come up with the latest technology and integrate it with immunoassay technology. Furthermore, the breakdown of the third covid-19 wave has partially slowed down the growth of the market as the spread is at lower levels
Key Takeaways from Market Study
The Immunoassay market is expected to increase with a market share of 35.0% in North America.
Asia Pacific is expected to account for 30% market share during the assessment year.
By product, reagents and kits accounted for 60% share of total revenue generated of the immunoassay market globally and is anticipated to hold the highest share by 2032, owing to the cost-effective products, fueling the overall sales of immunoassay testing instrument
EIA/ELISA technology gains the highest traction in the market by technology with a market share of 60% and its growth owing to higher use of it in reducing the assay time for immunoelectrophoretic and immunodiffusion while providing accurate and quantitive results.
“Immunoassay market analysis displays the higher growth prospects due to the higher awareness of the new viruses and diseases that demand for higher antibodies in the body. An immunoassay test gives you information about the antibodies present in the body for any specific virus or disease spread by it. Demand for immunoassay tests rises as the hospitals, clinics, and research and development centers established by the government are consuming the most from the market” says a Future Market Insights analyst.
New market research report on immunoassay defines the market space as a younger space where there is a space for innovation and technology. The defining factors key players have been the ability to deliver effective and accurate results while making the product more logistics friendly and easy to use.
Siemens Healthineers has introduced its latest and revised fully automated immunoassay platforms and a comprehensive and disease-specific chart in excess of 100 tests. This enhanced productivity and efficiency while delivering accurate and faster results.
Biomerieux, with more than 26000 immunoassay systems globally has introduced its R7D programs that covers high medical value applications, increased automation and decentralized testing, flourishing the sales of immunoassay platforms.
Abbott Laboratories focuses on chia technology and offers an automatic immunoassay analyzer named Abbott prism, delivers effectiveness and enhances productivity.
Visit for Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-15437
Explore More Valuable Insights
Future Market Insights, in its new report, offers an impartial analysis of the global Immunoassay market, presenting historical data (2017-2021) and estimation statistics for the forecast period of 2022-2032.
The study offers compelling insights based on Application (Food, Beverage, Pharmaceuticals, Other (Applications), Form (Natural Immunoassay, Synthetic Immunoassay), Region (North America, Latin America, Europe, East Asia, South Asia, Oceania, MEA)
Immunoassay Market by Category
By Product, Immunoassay Market is segmented as:
Reagents & Kits
Software & Services
By Technology, Immunoassay Market is segmented as:
Enzyme Immunoassays (EIA)Rapid Test
Chemiluminescence Immunoassays (CLIA)
Fluorescence Immunoassays (FIA)
By End-use, Immunoassay Market is segmented as:
Therapeutic Drug Monitoring
Infectious Disease Testing
By Application, Immunoassay Market is segmented as:
Pharmaceutical and Biotech Companies
Academic Research Centers
By Form, Immunoassay Market is segmented as:
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
Explore FMI’s Extensive ongoing Coverage on Healthcare Domain
Sonohysterography Catheters Market: The sonohysterography catheters market is likely to cross an estimated market value of US$ 22.5 Million by 2032, while it strengthens its hold in the global market at a CAGR of 5.2% (2022-2032).
Osteotomy Plates Market: The osteotomy plates market is forecasted to be appraised at US$ 949 million by 2032, up from US$ 662.1 million in 2022, advancing at a CAGR of 3.3% during the forecast period.
Stabilometric Platform Market: The stabilometric platform market value is estimated to be around US$ 1.0 Billion in 2022. The overall market share is anticipated to reach US$ 2.1 Billion by 2032 with a CAGR of 7.4% by 2032.
Osteonecrosis Treatment Market: The osteonecrosis treatment market is like to reach US$ 461.7 million by 2032, up from US$ 275.3 million in 2022, expanding at a CAGR of 4.80% during the forecast period.
Veterinary Orthotics-Prosthetics Market: The veterinary orthotics-prosthetics market is anticipated to reach US$ 164.9 Million in 2032, and is anticipated to grow at a CAGR of 9.4% during the forecast period.
Neuro Immunoassay Market: The neuro immunoassay market is projected to be valued at US$ 5553.2 million by 2032, up from US$ 2456.1 million in 2022, increasing at a CAGR of 7.70% during the forecast period.
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Future Market Insights Inc.
200 Continental Drive,
Suite 401, Newark,
Delaware - 19713, USA
For Sales Enquiries: firstname.lastname@example.org
Browse all Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs